Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novavax Inc
(NQ:
NVAX
)
13.30
+1.16 (+9.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax Inc
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
59
60
Next >
Omicron More Severe For Unvaccinated Children Than Other Strains, Hong Kong Study Finds: Bloomberg
March 31, 2022
According to a Hong Kong-based study, the omicron variant of COVID-19 has been linked to more hospitalizations, severe complicat
Via
Benzinga
If You Invested $1000 In Novavax 5 Years Ago, Here's How Much You Would Have Today
March 30, 2022
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 12.42% on an annualized basis producing an average annual return of 26.64%. Currently, Novavax has a market capitalization of...
Via
Benzinga
EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine
March 30, 2022
Via
Benzinga
Novavax Stock Is a Bet on Interest From Unvaccinated People
March 30, 2022
NVAX stock represents a vaccine that lacks approval. There is real appeal behind the narrative, as it may appeal to unvaccinated people.
Via
InvestorPlace
Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness
March 29, 2022
President Biden's budget proposal calls for $81.7 billion to spend over five years preparing for future pandemics, which would be a significant investment in boosting the country
Via
Benzinga
Novavax's COVID-19 Vaccine Scores Green Light In India with First Approval For Adolescents
March 23, 2022
Via
Benzinga
Why Novavax Stock Is Due for a Comeback Soon
March 22, 2022
As Novavax has its Covid-19 vaccine authorized in multiple major world markets, NVAX stock is overdue for a re-rating on Wall Street.
Via
InvestorPlace
Looking At Novavax's Recent Whale Trades
March 28, 2022
Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC
March 24, 2022
The COVID-19 pandemic has led to over 6 million fatalities. The scientists are still studying why most children do not suffer badly from coronavirus infection.
Via
Benzinga
5 Cheap Energy Stocks Riding Oil Higher
March 23, 2022
Energy is understandably at the top of every investor's mind right now, but finding the best energy stocks requires careful consideration.
Via
InvestorPlace
The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
March 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Novavax’s Success Depends on the FDA’s Decision
March 23, 2022
While Novavax awaits FDA approval, the frustration amongst investors is rising and a lot is on stake. Take a small position in NVAX stock.
Via
InvestorPlace
This Is What Whales Are Betting On Novavax
March 22, 2022
Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Will Another Covid Booster Save Vaccine Stocks Moderna, BioNTech?
March 21, 2022
Vaccine stocks remain under pressure despite a push for another round of Covid shots.
Via
Investor's Business Daily
Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC
March 21, 2022
U.S. health experts warn that an emerging, highly contagious COVID-19 omicron variant, BA.2, could soon increase domestic coronavirus cases.
Via
Benzinga
Novavax Whale Trades For March 18
March 18, 2022
Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Check Out What Whales Are Doing With NVAX
March 17, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 23 strange trades.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Investors Should Not Lose Faith in Novavax
March 16, 2022
The valuation of NVAX stock is quite attractive while Novavax continues to make progress in many important areas.
Via
InvestorPlace
WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC
March 16, 2022
The WHO Foundation CEO, Anil Soni, has told CNBC that the global economy will lose “trillions of dollars” if more COVID-19 vaccines aren&
Via
Benzinga
Check Out What Whales Are Doing With NVAX
March 15, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 14 strange trades.
Via
Benzinga
Best Biotech Stocks To Buy In 2022
March 15, 2022
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and...
Via
Talk Markets
Hopes For A Peace Accord
March 14, 2022
The winner today was BioNTech up 14.89% on hopes for new sales for the Covid-19 variant.
Via
Talk Markets
Why Is Novavax (NVAX) Stock in the Spotlight Today?
March 14, 2022
Novavax is once again in the spotlight as China reports near-record numbers of Covid cases. What's going on with NVAX stock?
Via
InvestorPlace
NASDAQ:NVAX Long Term Investor Notice: Investigation of Potential Wrongdoing at Novavax, Inc.
March 14, 2022
San Diego, CA -- (SBWIRE) -- 03/14/2022 -- Certain directors of Novavax, Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Here's Why Pfizer And Novavax Shares Are Rising On Monday
March 14, 2022
Pfizer Inc. (NYSE:PFE) and Novavax, Inc.
Via
Benzinga
50 Stocks Moving In Monday's Mid-Day Session
March 14, 2022
Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share. AgriFORCE Growing Systems,...
Via
Benzinga
Chart Wars: Between Moderna And Novavax, Which COVID Stock Will Soar Higher?
March 09, 2022
Moderna, Inc (NASDAQ: MRNA) and Novavax, Inc (NASDAQ: NVAX) were trading up over 10% and 8%, respectively, at one point on Wednesday, boosted by the S&P 500’s...
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much
March 09, 2022
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 10.65% on an annualized basis. Buying $100 In NVAX: 5 years ago, an investor could have purchased 3.47...
Via
Benzinga
Novavax's COVID-19 Shot Inches Up To FDA Authorization: WSJ
March 07, 2022
Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine is moving toward U.S. authorization after the Company said it resolved manufacturing problems that had held up its...
Via
Benzinga
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.